Resolution criteria on PolyGram: As of market creation, CVS Health is estimated to release earnings on May 6, 2026. The Street consensus estimate for CVS Health’s non-GAAP EPS for the relevant quarter is $2.21 as of market creation. This market will resolve to "Yes" if CVS Health reports non-GAAP EPS greater than $2.21 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the non-GAAP EPS listed in the company’s official earnings documents. If CVS Health releases earnings without non-GAAP EPS, then the market will resolve according to the non-GAAP EPS figure reported by SeekingAlpha.
PolyGram is an on-chain prediction market where you trade YES or NO outcome shares with real USDC on Polygon. For this market, buy YES if you believe the event will happen, or NO if you think it won't. Your maximum loss is your stake — winning shares pay $1.00 each at resolution. Unlike sportsbooks, there is no house edge: prices are set by supply and demand from other traders and reflect the crowd's real-time probability.
Market outcomes
| Will CVS Health (CVS) beat quarterly earnings? | 100% YES | 0% NO |
CVS Health will report first-quarter 2026 earnings on 6 May, with the market resolving based on whether non-GAAP EPS exceeds the consensus estimate of $2.21. The current order book on Polymarket reflects a 100% implied probability of a beat, suggesting traders are pricing in minimal downside risk or that the consensus figure has drifted sufficiently below management guidance to make an earnings miss unlikely.
CVS has a mixed recent track record on earnings surprises. The company beat EPS estimates in three of its last four quarters, though margins have faced pressure from pharmacy reimbursement headwinds and increased competition in the healthcare services segment. When consensus estimates sit this low relative to forward guidance, historical patterns show elevated beat probabilities, particularly for large-cap healthcare operators with diversified revenue streams across pharmacy, insurance, and clinics.
Key variables for traders monitoring this outcome include any interim guidance revisions from CVS management, shifts in pharmacy reimbursement rates announced by major payers, and performance of its Aetna insurance division—which has become material to overall earnings. Recent healthcare sector earnings have shown resilience in cost management despite inflationary pressures, though CVS specifically flagged margin compression risks in its last quarterly call. Any material M&A announcements or significant changes to store footprint before the earnings date could alter underlying fundamentals, though such moves are typically telegraphed in advance.
CVS Health Corporation is an American multinational healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; and Aetna, a health insurance provider, among many other brands. The company is the world's second largest healthcare company, behind UnitedHealth Group. In 2023, the company was ranked 64th in the
The CVS Health Charity Classic was a professional golf tournament. It was contested annually as a one-day, three-person team event. Each team is made up of one player from each of three Tours: PGA Tour, PGA Tour Champions, and LPGA Tour. The top two scores at each hole for the team count towards the team's final score.
The health of domestic cats is a well studied area in veterinary medicine.
CHI Health Center Omaha is an arena and convention center in Downtown Omaha, Nebraska, United States. Operated by the Metropolitan Entertainment & Convention Authority (MECA), the 1.1-million-square-foot (100,000 m2) facility has an 18,975-seat arena, a 194,000 sq ft (18,000 m2) exhibition hall, and 62,000 sq ft (5,800 m2) of meeting space. The arena hosts b
This market settles from the official outcome published at https://seekingalpha.com/. A proposer submits the final result to the UMA optimistic oracle on Polygon; the two-hour dispute window closes and payouts clear in USDC.
The mechanics for trading "Will CVS Health (CVS) beat quarterly earnings?" are the same as any other PolyGram event contract. Each YES share resolves to $1 if the event happens, or $0 if it doesn't. The current price between 0¢ and 100¢ is the market's probability estimate, set live by the order book.
$1K in lifetime turnover and $0 of resting liquidity puts this market in the below the median by volume for finance contracts on PolyGram. Order-book depth is thin — large orders may need to be split across the book or executed as limit orders.
The market has been open for under a month — fresh enough that information asymmetry remains a real factor.
Higher-volume markets tend to have tighter spreads and faster price discovery — meaning the displayed YES/NO percentages are more likely to reflect the true crowd-implied probability rather than a single trader's directional view.
As of today, traders on Polymarket price this outcome at 100%. The number updates continuously as the order book clears. PolyGram mirrors the same live odds with locale-aware formatting and USDC settlement.
Resolution is sourced from https://seekingalpha.com/. Settlement is executed by the UMA optimistic oracle on Polygon, with a 2-hour dispute window before payouts clear.
This prediction market is scheduled to close on 6 May 2026. After the resolving event occurs, settlement typically clears within 24 hours once the UMA optimistic oracle confirms the outcome. All payouts are in USDC on the Polygon network.
To trade on this prediction market, create a free PolyGram account at polygram.ink, deposit USDC via Polygon, and place a YES or NO order on the outcome you believe in. You can learn more on our how-it-works page. Your maximum loss is limited to your stake — there is no leverage or margin.
When the outcome is determined, winning YES shares pay out $1.00 each in USDC, while losing shares pay $0. Settlement is handled by the UMA optimistic oracle on Polygon — a proposer submits the result, a two-hour dispute window opens, and if uncontested, payouts are distributed automatically. You can withdraw your winnings to any Polygon wallet.
Prediction-market positions can lose 100% of staked capital. Outcomes are uncertain by definition — historical accuracy of crowd-implied probabilities is high in aggregate but not for any single market. PolyGram does not provide investment advice. Trade only with capital you can afford to lose.
Regulatory status varies by jurisdiction. Germany, the United States, and most EU countries treat Polymarket-style event contracts under one of three frameworks: financial derivative, gambling product, or unregulated novel asset. Consult local counsel before trading.
Explore more prediction market odds and trading opportunities on PolyGram: